ABOUT THE JOURNAL
The Southern African Journal of HIV Medicine is focused on HIV/AIDS treatment, prevention and related topics relevant to clinical and public health practice. The purpose of the journal is to disseminate original research results and support high-level learning related to HIV Medicine. It publishes original research articles, editorials, case reports/case series, reviews of state-of-the-art clinical practice and correspondence. View our Editorial Team.


Quick links:

 LATEST ARTICLES

Original Research

 
Trends in body mass index in the pre-dolutegravir period in South Africa  
Florian van Ginkel, Roos E. Barth, Hugo Tempelman, Kerstin Klipstein-Grobusch, Diederick E. Grobbee, Karine Scheuermaier, Francois W.D. Venter, Alinda G. Vos-Seda
23 April 2024

Guideline

 
Management of drug-induced liver injury in people with HIV treated for tuberculosis: 2024 update  
Tom Boyles, Rebecca H. Berhanu, Neliswa Gogela, Hannah Gunter, Tamsin Lovelock, Ndiviwe Mphothulo, Arifa Parker, Helena Rabie, Lauren Richards, Phumla Sinxadi, Camilla Wattrus, Mahomed-Yunus Moosa
30 March 2024

Review Article

 
Inflammatory mechanisms contributing to retinal alterations in HIV infection and long-term ART  
Lungile M. Buthelezi, Alvin J. Munsamy, Khathutshelo P. Mashige
26 March 2024

Original Research

 
Effects of the COVID-19 pandemic on early infant diagnosis of HIV in Cape Town, South Africa  
Hendrike van Vollenhoven, Emma Kalk, Stuart M. Kroon, Tafadzwa Maseko, Florence Phelanyane, Jonathan Euvrard, Lezanne Fourie, Nicolene le Roux, Phumza Nongena
18 March 2024

Original Research

 
Retrospective review of maternal HIV viral load electronic gatekeeping codes in South Africa  
Siphesihle K. Mahanjana, Tladi Ledibane, Gayle G. Sherman, Tanya Y. Murray, Ahmad F. Haeri Mazanderani
20 February 2024

Scientific Letter

 
Very low HIV positivity on paediatric surgical wards in Mozambique: Implications for inpatient provider-initiated testing programmes  
Henriques Viola, Angela Bi, Dalva Khosa, Zacarias Mateus, Massada Da Rocha, Vanda Amado, Atanásio Taela, Daniel A. DeUgarte, Andreas Schindele, W. Chris Buck
08 January 2024

Original Research

 
Outcomes and characteristics of patients on protease inhibitors at a tertiary level antiretroviral clinic  
Michele Perks, Denasha L. Reddy, Francois Venter
21 December 2023

Review Article

 
Country ownership and sustainable programming of the HIV response in South Africa: A scoping review  
Refilwe N. Phaswana-Mafuya, Edith Phalane, Haley Sisel, Lifutso Motsieloa, Katherine Journeay, Vuyiseka Dubula, Jabulile Sibeko, Pholokgolo Ramothwala
30 November 2023

Scientific Letter

 
Dolutegravir resistance in three pregnant and breastfeeding women in South Africa  
Ninke Fourie, Kate Rees, Denis Mali, Bridget Mugisa, Cara O’Connor, Natasha Davies
28 November 2023

Reviewer Acknowledgement

 
Acknowledgement to Reviewers  
Editoial Office
16 November 2023
More Latest Articles...
FAST FACTS 2018- STATISTICS (UPDATED DAILY)
239 PUBLISHED
CONTENT
3070 CROSSREF
CITATIONS
2015186 TOTAL
DOWNLOADS
 ANNOUNCEMENTS

Notification: Get ready for our latest article!

 

Virologic outcomes with tenofovir-lamivudine-dolutegravir in adults failing PI-based second-line ART’ authored by Ying Zhao, Jacqueline Voget, Isaac Singini, Zaayid Omar, Vanessa Mudaly, Andrew Boulle, Gary Maartens and Graeme Meintjes is on its way. Stay tuned for thought-provoking insights and valuable information coming your way 26 April 2024! Contribution excerpt: ‘This study supports switching to TLD as a third-line regimen or an alternative second-line regimen after PI regimen failure in a programmatic setting, with the caveat that patients switched to TLD in our study had no tenofovir resistance.'

 
Posted: 2024-04-22

Advertisement: CPD for Healthcare Professionals

 
CPD courses accredited by the HPCSA, HPCNA, and AHPCSA. The HPCSA and HPCNA have accepted the principle of cross recognition of CEUs. Visit AOSIS eCPD to earn your CEU points.  
Posted: 2022-01-28

Press Release: Online Resource & News Portal - Department of Health, Republic of South Africa

 
Visit www.sacoronavirus.co.za for up to date information about the COVID-19 Pandemic. Hotline: 0800 029 999 | WhatsApp: 0600-123456  
Posted: 2022-01-28
More Announcements...